Analyst Ratings for Blueprint Medicines (BPMC) [Sells]
BPMC Rating Summary
BPMC Price Target Summary
- Highest: $125.00 (H.C. Wainwright)
- Lowest: $43.00 (Leerink Partners)
- Average: $85.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$85.71 (-5.5%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$85.71 (-5.5%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/5/2023 | Leerink Partners | Andrew Berens | Downgrade | Underperform (Market Perform) |
43.00 (48.00) |
58.22 (90.74) |
55.86% | Details |
| 6/10/2022 | Citi » Updated 5/24/2023 |
David Lebowitz | Downgrade | Sell (Neutral) |
46.00 (44.00) |
64.50 (90.74) |
40.68% | Details |
